Journal of Clinical Oncology, Vol 12, 725-729, Copyright © 1994 by American Society of Clinical Oncology

ARTICLES

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction

M Gerhard, H Juhl, H Kalthoff, HW Schreiber, C Wagener and M Neumaier
Abteilung fur Klinische Chemie, Universitats-Krankenhaus Eppendorf, Hamburg, Germany.

PURPOSE: To establish a sensitive assay for the specific detection of carcinoembryonic antigen (CEA)-expressing tumor cells in the bone marrow of patients with colorectal cancer and other CEA-positive carcinomas. PATIENTS AND METHODS: A CEA-specific nested reverse transcriptase (RT) polymerase chain reaction (PCR) assay was developed and optimized using limiting dilutions of a CEA-positive cancer cell line mixed with normal bone marrow cell specimens. The optimized test was then used to examine bone marrow samples obtained from 15 patients with abdominal carcinomas (colorectal, n = 10; pancreatic, n = 3; gastric, n = 2) and six patients with breast cancer. Specificity was assessed by examination of 56 negative controls (malignant hematologic disease, n = 28; nonmalignant disease conditions, n = 5; healthy bone marrow donors, n = 8; normal peripheral-blood samples, n = 15). For 11 patients with abdominal carcinomas, immunostaining evaluations were performed using an anti-CEA and an anticytokeratin antibody, and the results compared with the nested PCR assay. RESULTS: In the sensitivity calibration system, single CEA-expressing tumor cells were detected in 2 to 5 x 10(7) normal bone marrow cells. All 56 control samples failed to amplify. This demonstrates that mRNAs coding for highly homologous CEA-related antigens expressed by various lineages of blood cells do not interfere. Bone marrow samples from 10 of 15 patients with abdominal cancers and four of six breast cancer patients scored positive, indicating micrometastatic bone disease. Four of 11 samples from the gastrointestinal cancer patients were found to be positive by the PCR method, but were negative with the immunocytology method. CONCLUSION: Since approximately 30% of the colorectal carcinoma patients that score negative in immunocytology staining of bone marrow samples have been reported to relapse, earlier diagnosis of the presence of malignant cells is needed. Our result that samples scoring positive in the described CEA-specific PCR test remained negative by two immunostaining methods suggests a higher sensitivity. We conclude that PCR amplification of CEA mRNA may lead to an earlier diagnosis of micrometastatic bone disease in patients with CEA-expressing carcinomas.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				T. Takai, S. Kanaoka, K.-i. Yoshida, Y. Hamaya, M. Ikuma, N. Miura, H. Sugimura, M. Kajimura, and A. Hishida Fecal Cyclooxygenase 2 Plus Matrix Metalloproteinase 7 mRNA Assays as a Marker for Colorectal Cancer Screening Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1888 - 1893. [Abstract] [Full Text] [PDF]

				C. Alix-Panabieres, S. Riethdorf, and K. Pantel Circulating Tumor Cells and Bone Marrow Micrometastasis Clin. Cancer Res., August 15, 2008; 14(16): 5013 - 5021. [Abstract] [Full Text] [PDF]

				K. Pantel, C. Alix-Panabieres, and S. Riethdorf Circulating Tumor Cells: Detection and Clinical Relevance Am. Assoc. Cancer Res. Educ. Book, April 12, 2008; 2008(1): 603 - 610. [Abstract] [Full Text] [PDF]

				Z. Liu, M. Jiang, J. Zhao, and H. Ju Circulating Tumor Cells in Perioperative Esophageal Cancer Patients: Quantitative Assay System and Potential Clinical Utility Clin. Cancer Res., May 15, 2007; 13(10): 2992 - 2997. [Abstract] [Full Text] [PDF]

				S Apostolaki, M Perraki, A Pallis, V Bozionelou, S Agelaki, P Kanellou, A Kotsakis, E Politaki, K Kalbakis, A Kalykaki, et al. Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance Ann. Onc., May 1, 2007; 18(5): 851 - 858. [Abstract] [Full Text] [PDF]

				S. Sadahiro, T. Suzuki, Y. Maeda, S. Yurimoto, S. Yasuda, H. Makuuchi, A. Kamijo, and C. Murayama Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Peripheral Blood 7 Days After Curative Surgery is a Novel Prognostic Factor in Colorectal Cancer Ann. Surg. Oncol., March 1, 2007; 14(3): 1092 - 1098. [Abstract] [Full Text] [PDF]

				D. Iddings, A. Ahmad, D. Elashoff, and A. Bilchik The Prognostic Effect of Micrometastases in Previously Staged Lymph Node Negative (N0) Colorectal Carcinoma: A Meta-analysis Ann. Surg. Oncol., November 1, 2006; 13(11): 1386 - 1392. [Abstract] [Full Text] [PDF]

				T. Setoyama, S. Natsugoe, H. Okumura, M. Matsumoto, Y. Uchikado, S. Ishigami, T. Owaki, S. Takao, and T. Aikou Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer. Clin. Cancer Res., October 15, 2006; 12(20): 5972 - 5977. [Abstract] [Full Text] [PDF]

				S. Sadahiro, T. Suzuki, K. Ishikawa, T. Saguchi, Y. Maeda, S. Yasuda, H. Makuuchi, S. Yurimoto, and C. Murayama Detection of Carcinoembryonic Antigen Messenger RNA-Expressing Cells in Portal and Peripheral Blood During Surgery Does Not Influence Relapse in Colorectal Cancer Ann. Surg. Oncol., December 1, 2005; 12(12): 988 - 994. [Abstract] [Full Text] [PDF]

				K. Passebosc-Faure, G. Li, C. Lambert, M. Cottier, A. Gentil-Perret, P. Fournel, M. Perol, and C. Genin Evaluation of a Panel of Molecular Markers for the Diagnosis of Malignant Serous Effusions Clin. Cancer Res., October 1, 2005; 11(19): 6862 - 6867. [Abstract] [Full Text] [PDF]

				S L Kong, M Salto-Tellez, A P K Leong, Y H Chan, and E S C Koay Discordant quantitative detection of putative biomarkers in nodal micrometastases of colorectal cancer: biological and clinical implications J. Clin. Pathol., August 1, 2005; 58(8): 839 - 844. [Abstract] [Full Text] [PDF]

				W. Janni, B. Rack, K. Lindemann, and N. Harbeck Detection of Micrometastatic Disease in Bone Marrow: Is It Ready for Prime Time? Oncologist, August 1, 2005; 10(7): 480 - 492. [Abstract] [Full Text] [PDF]

				Y. Mataki, S. Takao, K. Maemura, S. Mori, H. Shinchi, S. Natsugoe, and T. Aikou Carcinoembryonic Antigen Messenger RNA Expression Using Nested Reverse Transcription-PCR in the Peripheral Blood During Follow-up Period of Patients Who Underwent Curative Surgery for Biliary-Pancreatic Cancer: Longitudinal Analyses Clin. Cancer Res., June 1, 2004; 10(11): 3807 - 3814. [Abstract] [Full Text] [PDF]

				K. Pantel, V. Muller, M. Auer, N. Nusser, N. Harbeck, and S. Braun Detection and Clinical Implications of Early Systemic Tumor Cell Dissemination in Breast Cancer Clin. Cancer Res., December 15, 2003; 9(17): 6326 - 6334. [Abstract] [Full Text] [PDF]

				M. Mitas, L. Hoover, G. Silvestri, C. Reed, M. Green, A. T. Turrisi, C. Sherman, K. Mikhitarian, D. J. Cole, M. I. Block, et al. Lunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral Blood J. Mol. Diagn., November 1, 2003; 5(4): 237 - 242. [Abstract] [Full Text] [PDF]

				Y.-W. Tien, P.-H. Lee, R.-H. Hu, S.-M. Hsu, and K.-J. Chang The Role of Gelatinase in Hepatic Metastasis of Colorectal Cancer Clin. Cancer Res., October 15, 2003; 9(13): 4891 - 4896. [Abstract] [Full Text] [PDF]

				G. Castaldo, R. Tomaiuolo, A. Sanduzzi, A. Ponticiello, I. Marchetiello, and F. Salvatore Carcinoembryonic antigen mRNA analysis detects micrometastatic cells in blood from lung cancer patients Eur. Respir. J., September 1, 2003; 22(3): 418 - 421. [Abstract] [Full Text] [PDF]

				B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up Mol. Pathol., June 1, 2003; 56(3): 172 - 179. [Abstract] [Full Text] [PDF]

				W. Sienel, R. Seen-Hibler, W. Mutschler, K. Pantel, and B. Passlick Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 451 - 456. [Abstract] [Full Text] [PDF]

				T. Marutsuka, S. Shimada, K. Shiomori, N. Hayashi, Y. Yagi, T. Yamane, and M. Ogawa Mechanisms of Peritoneal Metastasis after Operation for Non-Serosa-invasive Gastric Carcinoma: An Ultrarapid Detection System for Intraperitoneal Free Cancer Cells and a Prophylactic Strategy for Peritoneal Metastasis Clin. Cancer Res., February 1, 2003; 9(2): 678 - 685. [Abstract] [Full Text] [PDF]

				S. Yamamoto, T. Akasu, S. Fujita, and Y. Moriya Long-term Prognostic Value of Conventional Peritoneal Cytology after Curative Resection for Colorectal Carcinoma Jpn. J. Clin. Oncol., January 1, 2003; 33(1): 33 - 37. [Abstract] [Full Text] [PDF]

				B M Ryan, F Lefort, R McManus, J Daly, P W N Keeling, D G Weir, and D Kelleher A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up Gut, January 1, 2003; 52(1): 101 - 108. [Abstract] [Full Text] [PDF]

				R. J. Feezor, E. M. Copeland III, and S. N. Hochwald Significance of Micrometastases in Colorectal Cancer Ann. Surg. Oncol., December 1, 2002; 9(10): 944 - 953. [Full Text] [PDF]

				E. S. Kass, J. W. Greiner, J. A. Kantor, K. Y. Tsang, F. Guadagni, Z. Chen, B. Clark, R. D. Pascalis, J. Schlom, and C. Van Waes Carcinoembryonic Antigen as a Target for Specific Antitumor Immunotherapy of Head and Neck Cancer Cancer Res., September 1, 2002; 62(17): 5049 - 5057. [Abstract] [Full Text] [PDF]

				S. Yokoyama and H. Yamaue Prediction of Distant Metastasis by Using Reverse Transcriptase-Polymerase Chain Reaction for Epithelial and Variant CD44 mRNA in the Peripheral Blood of Patients With Colorectal Cancer Arch Surg, September 1, 2002; 137(9): 1069 - 1073. [Abstract] [Full Text] [PDF]

				J.-i. Yamashita, A. Matsuo, Y. Kurusu, T. Saishoji, N. Hayashi, and M. Ogawa Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: A prospective study J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 299 - 305. [Abstract] [Full Text] [PDF]

				R K B Dang, R S Anthony, J I O Craig, R C F Leonard, and A C Parker Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer Mol. Pathol., June 1, 2002; 55(3): 177 - 181. [Abstract] [Full Text] [PDF]

				K. Uchikura, S. Takao, A. Nakajo, F. Miyazono, S. Nakashima, K. Tokuda, M. Matsumoto, H. Shinchi, S. Natsugoe, and T. Aikou Intraoperative Molecular Detection of Circulating Tumor Cells by Reverse Transcription-Polymerase Chain Reaction in Patients With Biliary-Pancreatic Cancer Is Associated With Hematogenous Metastasis Ann. Surg. Oncol., May 1, 2002; 9(4): 364 - 370. [Abstract] [Full Text] [PDF]

				J. D'Cunha, A. L. Corfits, J. E. Herndon II, J. A. Kern, L. J. Kohman, G. A. Patterson, R. A. Kratzke, and M. A. Maddaus Molecular staging of lung cancer: Real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of cancer and leukemia group B trial 9761 J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 484 - 491. [Abstract] [Full Text] [PDF]

				K. Kaneko, M. Yano, T. Yamano, T. Tsujinaka, H. Miki, Y. Akiyama, M. Taniguchi, Y. Fujiwara, Y. Doki, M. Inoue, et al. Detection of Peritoneal Micrometastases of Gastric Carcinoma with Green Fluorescent Protein and Carcinoembryonic Antigen Promoter Cancer Res., July 1, 2001; 61(14): 5570 - 5574. [Abstract] [Full Text] [PDF]

				Y.-W. Tien, K.-J. Chang, Y.-M. Jeng, P.-H. Lee, M.-S. Wu, J.-T. Lin, and S.-M. Hsu Tumor Angiogenesis and Its Possible Role in Intravasation of Colorectal Epithelial Cells Clin. Cancer Res., June 1, 2001; 7(6): 1627 - 1632. [Abstract] [Full Text] [PDF]

				F. Guadagni, J. Kantor, S. Aloe, M. D. Carone, A. Spila, R. D’Alessandro, M. R. Abbolito, M. Cosimelli, F. Graziano, F. Carboni, et al. Detection of Blood-borne Cells in Colorectal Cancer Patients by Nested Reverse Transcription-Polymerase Chain Reaction for Carcinoembryonic Antigen Messenger RNA: Longitudinal Analyses and Demonstration of Its Potential Importance as an Adjunct to Multiple Serum Markers Cancer Res., March 1, 2001; 61(6): 2523 - 2532. [Abstract] [Full Text]

				N. Masuda, Y. Tamaki, I. Sakita, M. Ooka, T. Ohnishi, M. Kadota, N. Aritake, K. Okubo, and M. Monden Clinical Significance of Micrometastases in Axillary Lymph Nodes Assessed by Reverse Transcription-Polymerase Chain Reaction in Breast Cancer Patients Clin. Cancer Res., November 1, 2000; 6(11): 4176 - 4185. [Abstract] [Full Text] [PDF]

				V. M. M. van Houten, M. P. Tabor, M. W. M. van den Brekel, F. Denkers, R. G. A. Wishaupt, J. A. Kummer, G. B. Snow, and R. H. Brakenhoff Molecular Assays for the Diagnosis of Minimal Residual Head-and-Neck Cancer: Methods, Reliability, Pitfalls, and Solutions Clin. Cancer Res., October 1, 2000; 6(10): 3803 - 3816. [Abstract] [Full Text]

				G. Castaldo, G. Calcagno, R. Sibillo, R. Cuomo, G. Nardone, L. Castellano, C. Del Vecchio Blanco, G. Budillon, and F. Salvatore Quantitative Analysis of Aldolase A mRNA in Liver Discriminates between Hepatocellular Carcinoma and Cirrhosis Clin. Chem., July 1, 2000; 46(7): 901 - 906. [Abstract] [Full Text] [PDF]

				J. Okami, K. Dohno, M. Sakon, K. Iwao, T. Yamada, H. Yamamoto, Y. Fujiwara, H. Nagano, K. Umeshita, N. Matsuura, et al. Genetic Detection for Micrometastasis in Lymph Node of Biliary Tract Carcinoma Clin. Cancer Res., June 1, 2000; 6(6): 2326 - 2332. [Abstract] [Full Text]

				J.-i. Yamashita, Y. Kurusu, N. Fujino, T. Saisyoji, and M. Ogawa Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential hazard for intraoperative hematogenous tumor cell dissemination J. Thorac. Cardiovasc. Surg., May 1, 2000; 119(5): 899 - 905. [Abstract] [Full Text] [PDF]

				Antonella De Luca, S. Pignata, A. Casamassimi, A. D’Antonio, C. Gridelli, A. Rossi, F. Cremona, V. Parisi, Andrea De Matteis, and N. Normanno Detection of Circulating Tumor Cells in Carcinoma Patients by a Novel Epidermal Growth Factor Receptor Reverse Transcription-PCR Assay Clin. Cancer Res., April 1, 2000; 6(4): 1439 - 1444. [Abstract] [Full Text]

				P. Kienle, J. Weitz, R. Klaes, M. Koch, A. Benner, T. Lehnert, C. Herfarth, and M. von Knebel Doeberitz Detection of Isolated Disseminated Tumor Cells in Bone Marrow and Blood Samples of Patients With Hepatocellular Carcinoma Arch Surg, February 1, 2000; 135(2): 213 - 218. [Abstract] [Full Text] [PDF]

				S.-K. Kraeft, R. Sutherland, L. Gravelin, G.-H. Hu, L. H. Ferland, P. Richardson, A. Elias, and L. B. Chen Detection and Analysis of Cancer Cells in Blood and Bone Marrow Using a Rare Event Imaging System Clin. Cancer Res., February 1, 2000; 6(2): 434 - 442. [Abstract] [Full Text]

				R. A. Ghossein, S. Bhattacharya, and J. Rosai Molecular Detection of Micrometastases and Circulating Tumor Cells in Solid Tumors Clin. Cancer Res., August 1, 1999; 5(8): 1950 - 1960. [Abstract] [Full Text] [PDF]

				K. Pantel, R. J. Cote, and O. Fodstad Detection and Clinical Importance of Micrometastatic Disease J Natl Cancer Inst, July 7, 1999; 91(13): 1113 - 1124. [Abstract] [Full Text] [PDF]

				O. Zach, H. Kasparu, O. Krieger, W. Hehenwarter, M. Girschikofsky, and D. Lutz Detection of Circulating Mammary Carcinoma Cells in the Peripheral Blood of Breast Cancer Patients Via a Nested Reverse Transcriptase Polymerase Chain Reaction Assay for Mammaglobin mRNA J. Clin. Oncol., July 1, 1999; 17(7): 2015 - 2015. [Abstract] [Full Text] [PDF]

				B. Mellado, L. Gutierrez, T. Castel, D. Colomer, M. Fontanillas, J. Castro, and J. Estape Prognostic Significance of the Detection of Circulating Malignant Cells by Reverse Transcriptase-Polymerase Chain Reaction in Long-Term Clinically Disease-free Melanoma Patients Clin. Cancer Res., July 1, 1999; 5(7): 1843 - 1848. [Abstract] [Full Text] [PDF]

				R. H. Brakenhoff, J. G. W. Stroomer, C. t. Brink, R. de Bree, S. M. Weima, G. B. Snow, and G. A. M. S. van Dongen Sensitive Detection of Squamous Cells in Bone Marrow and Blood of Head and Neck Cancer Patients by E48 Reverse Transcriptase-Polymerase Chain Reaction Clin. Cancer Res., April 1, 1999; 5(4): 725 - 732. [Abstract] [Full Text] [PDF]

				A. E.H. Merrie, K. Yun, J. L. McCall, R. A. Ghossein, P. J. Bostick, D. S.B. Hoon, R. J. Cote, G.-J. Liefers, A.-M. Cleton-Jansen, and R. A.E.M. Tollenaar Detection of Carcinoembryonic Antigen Messenger RNA in Lymph Nodes from Patients with Colorectal Cancer N. Engl. J. Med., November 26, 1998; 339(22): 1642 - 1644. [Full Text]

				J. D. Luketich, E. S. Kassis, S. P. Shriver, N. T. Nguyen, P. R. Schauer, T. L. Weigel, S. A. Yousem, and J. M. Siegfried Detection of micrometastases in histologically negative lymph nodes in esophageal cancer Ann. Thorac. Surg., November 1, 1998; 66(5): 1715 - 1718. [Abstract] [Full Text] [PDF]

				G.-J. Liefers, A.-M. Cleton-Jansen, C. J.H. van de Velde, J. Hermans, J. H.J.M. van Krieken, C. J. Cornelisse, and R. A.E.M. Tollenaar Micrometastases and Survival in Stage II Colorectal Cancer N. Engl. J. Med., July 23, 1998; 339(4): 223 - 228. [Abstract] [Full Text] [PDF]

				A. Lindblom Improved Tumor Staging in Colorectal Cancer N. Engl. J. Med., July 23, 1998; 339(4): 264 - 265. [Full Text]

				Y. Kurusu, J.-i. Yamashita, N. Hayashi, S. Mita, N. Fujino, and M. Ogawa The sequence of vessel ligation affects tumor release into the circulation J. Thorac. Cardiovasc. Surg., July 1, 1998; 116(1): 107 - 113. [Abstract] [Full Text]

				E. Racila, D. Euhus, A. J. Weiss, C. Rao, J. McConnell, L. W. M. M. Terstappen, and J. W. Uhr Detection and characterization of carcinoma cells in the blood PNAS, April 14, 1998; 95(8): 4589 - 4594. [Abstract] [Full Text] [PDF]

				P. Tschentscher, C. Wagener, and M. Neumaier Sensitive and specific cytokeratin 18 reverse transcription-polymerase chain reaction that excludes amplification of processed pseudogenes from contaminating genomic DNA Clin. Chem., December 1, 1997; 43(12): 2244 - 2250. [Abstract] [Full Text] [PDF]

				I. Yoshino, H. Yokoyama, T. Yano, T. Ueda, E. Takai, K. Mizutani, H. Asoh, and Y. Ichinose Skip Metastasis to the Mediastinal Lymph Nodes in Non-Small Cell Lung Cancer Ann. Thorac. Surg., October 1, 1996; 62(4): 1021 - 1025. [Abstract] [Full Text]